EIOPA sharpens scrutiny of private-equity-backed insurers

Firms linked to private equity should prepare evidence explaining acquisition financing, distributions, risk transfer, liquidity and governance when competent authorities review the undertaking. EIOPA’s supervisory statement addresses those authorities and sets out where it expects them to focus before authorisation and during ongoing supervision.

The EIOPA supervisory statement, issued by the European Insurance and Occupational Pensions Authority, seeks "consistent, high-quality and risk-based supervision" of private-equity-related insurers and reinsurers across the EU. It is addressed to competent authorities under Article 29(2) of Regulation (EU) No 1094/2010.

This is supervisory convergence guidance, not a new Level 1 obligation or an amendment to Solvency II through delegated legislation. Its practical effect is to direct national authorities towards particular risks and the evidence they may request; it does not create a uniform new filing duty.

Authorisation will test the financing structure

EIOPA advises authorities to scrutinise the entire financing structure before authorising an acquisition, request justifications for each ownership level and test business plans against adverse financial scenarios.

That focus reaches beyond an ownership chart. Authorities may examine acquisition debt, upstream distributions, intermediate holding companies and entities in jurisdictions with non-equivalent regulatory regimes. The statement identifies unnecessary complexity as a barrier to effective oversight.

The statement also places capital extraction within the policyholder-protection analysis. EIOPA says supervisors "must ensure" that high distributions to shareholders or other short-term measures do not weaken an undertaking’s long-term viability or put policyholders and beneficiaries at risk.

That language supports closer examination of distribution plans and their balance-sheet effects. It does not prescribe a new EU-wide distribution cap.

EIOPA’s chair Petra Hielkema said supervision should focus on risks rather than the identity of an insurer’s owners, while recognising that new ownership structures or business models can create additional complexity or risk. The statement therefore does not make private-equity ownership a proxy for supervisory failure.

Ongoing supervision follows the operating model

The statement identifies changes in allocations to private credit and alternative assets, affiliated-business exposures, leverage, cost reduction and balance-sheet optimisation as matters for supervisory assessment under the prudent person principle and sound management requirements.

Complex, illiquid or difficult-to-value assets bring valuation and liquidity questions into the review. Where an insurer’s assets support other businesses in the same private-equity group, authorities are directed to assess concentration risks and conflicts of interest. The analytical read-across is that firms should be able to explain how investment and related-party decisions remain consistent with their insurance obligations.

Reinsurance receives separate treatment. EIOPA refers to intra-group and third-country arrangements and says supervisors should pay particular attention to effective risk transfer, while taking counterparty, liquidity and recapture risks into account.

The statement directs attention to the substance of the arrangement rather than its capital treatment alone. A reduction in capital requirements does not remove the need to explain where risk sits, how it is transferred and what liquidity or counterparty exposures remain. That is an evidence implication drawn from EIOPA’s supervisory emphasis, not a new reporting return.

Governance is the other recurring control. EIOPA says supervisors should ensure that management decisions remain independent and serve policyholders and beneficiaries through a sound and effective system of governance. This is relevant where general partners exercise direct or indirect control over portfolio companies, but the statement does not replace existing governance requirements with a private-equity-specific approval test.

National application will determine the signal

The competent authority handling an authorisation remains the decision-maker. EIOPA has set out the risks and supporting analysis it expects authorities to consider, while national supervisors apply the relevant authorisation and Solvency II processes to individual undertakings.

The same distinction applies to existing insurers and reinsurers. The statement can shape supervisory requests, governance discussions and assessments of business-model changes, but it does not, on the supplied text, create an automatic remediation deadline, prohibit private-equity ownership or determine the outcome of an individual authorisation.

The immediate response for firms is an exposure assessment covering ownership and financing layers, distributions and leverage, private-credit and alternative-asset allocations, affiliated-business exposures, intra-group and third-country reinsurance, valuation, liquidity, recapture risk and management independence. That assessment is a possible response to EIOPA’s expectations, not a standalone filing duty.

The next observable test is national-authority use of the statement in authorisation files and ongoing supervisory dialogue. Firms with relevant links should be ready to explain their structures and controls when competent authorities examine them.